BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 24566292)

  • 21. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
    Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
    Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving malignancy prediction in breast lesions with the combination of apparent diffusion coefficient and dynamic contrast-enhanced kinetic descriptors.
    Nogueira L; Brandão S; Matos E; Gouveia Nunes R; Ferreira HA; Loureiro J; Ramos I
    Clin Radiol; 2015 Sep; 70(9):1016-25. PubMed ID: 26135541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
    Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
    Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravoxel Incoherent Motion Diffusion-Weighted Imaging Versus Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Comparison of the Diagnostic Performance of Perfusion-Related Parameters in Breast.
    Jiang L; Lu X; Hua B; Gao J; Zheng D; Zhou Y
    J Comput Assist Tomogr; 2018; 42(1):6-11. PubMed ID: 28786902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
    Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Simplified Approach to Measure the Effect of the Microvasculature in Diffusion-weighted MR Imaging Applied to Breast Tumors: Preliminary Results.
    Teruel JR; Goa PE; Sjøbakk TE; Østlie A; Fjøsne HE; Bathen TF
    Radiology; 2016 Nov; 281(2):373-381. PubMed ID: 27128662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
    An YY; Kim SH; Kang BJ; Lee AW
    J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.
    Cakir O; Arslan A; Inan N; Anık Y; Sarısoy T; Gumustas S; Akansel G
    Eur J Radiol; 2013 Dec; 82(12):e801-6. PubMed ID: 24099642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.